Safety and Efficacy of Two Types of Influenza Vaccination in Heart Transplant Recipients: A Prospective Randomised Controlled Study
- 1 May 2005
- journal article
- clinical trial
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (5) , 588-592
- https://doi.org/10.1016/j.healun.2004.03.004
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The pathogenesis and management of influenza virus infection in organ transplant recipientsTransplant Infectious Disease, 2002
- Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adultsVaccine, 2000
- INFLUENZA VACCINATION DOES NOT PROMOTE CELLULAR OR HUMORAL ACTIVATION AMONG HEART TRANSPLANT RECIPIENTSTransplantation, 2000
- INFLUENZAInfectious Disease Clinics of North America, 2000
- Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderlyVaccine, 1999
- Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasonsVaccine, 1998
- Development of an Adjuvant to Enhance the Immune Response to Influenza Vaccine in the ElderlyBiologicals, 1997
- The Immunogenicity of Influenza Virus Vaccine in Solid Organ Transplant RecipientsClinical Infectious Diseases, 1996
- Influenza A in Immunocompromised PatientsClinical Infectious Diseases, 1993
- Influenza vaccination in renal transplant recipientsPublished by American Medical Association (AMA) ,1978